THIS CONTRACT INCLUDES PRECLINICAL AND MANUFACTURING DEVELOPMENT ACTIVITIES INCLUDING CELL LINE DEVELOPMENT PROCESS DEVELOPMENT NON-CLINICAL EFFICACY STUDIES NON-CLINICAL SAFETY STUDIES MANUFACTURING ACTIVITIES CLINICAL ACTIVITIES AND ALL AS
$65,806,222
| Recipient | BIOFACTURA INC UEI C1ZWQAYK4J58 |
|---|---|
| Award ID | 75A50119C00054 |
| Award amount | $65,806,222 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response |
| NAICS | 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| PSC | AN41 |
| Start date | Sep 26, 2019 |
| End date | Mar 31, 2026 |
| Place of performance | FREDERICK, MD |
| Record updated | Sep 23, 2025 |
View the official award record
More awards won by BIOFACTURA INC
PHASE II SBIR FOR PROCESS DEVELOPMENT AND MANUFACTURE OF AN ANTIBODY-BASED THERAPY AGAINST MARBURGVIRUS.
Department of Defense · $999,399 · Jun 15, 2020
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids